The latest research report on Bio-Pharma Market delivers a comprehensive study on current market trends. The outcome also includes revenue forecasts, statistics, market valuations which illustrate its growth trends and competitive landscape as well as the key players in the business.
Bio-Pharma Market Size
Global Bio-Pharma Market is valued at USD 274.10 Billion in 2020 and expected to reach USD 703.28 Billion by 2027 with the CAGR of 12.5% over the forecast period.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.com/requestSample/PostId/1593
Biopharmaceuticals, also known as bio-pharma, are the intersection of biotechnology and pharmaceutical production. Biopharmaceuticals are medicines produced in a laboratory that are structurally similar to compounds found in nature. The application of living organisms or extractions, by-products, or components of living organisms to prevent, relieve, or treat diseases come under the bio-pharma. Biopharmaceuticals are revolutionizing medicine and saving the lives of thousands of people. Biopharmaceutical is helping patients with cancer, diabetes, cardiovascular disease, immune disorders, and other illnesses, as they offer targeted treatment with fewer side effects. Biopharmaceuticals are used to make vaccines, blood and blood components, allergenic for allergy treatment, body cells and tissues, living cells for cell therapies, gene therapies, and recombinant therapeutic proteins.
During Covid-19, economies around the world are suffering, businesses are experiencing losses, workers lost their job, and many people are facing the complete upheaval of lifestyle. The COVID-19 outbreak has put a significant burden on healthcare systems. However, biopharmaceutical companies taking center stage in the Covid-19 fight. Almost all of the region’s biopharmaceutical companies have been working on developing effective COVID-19 treatments which has shown a positive impact on the growth of Bio-pharma market.
The regions covered in this Global Bio-Pharma Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of global Bio-Pharma is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Major players in the global Bio-Pharma market are
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca PLC
- Bristol-Myers Squibb
- Eli Lilly and Company
- Johnson and Johnson
- Merck & Co. Inc.
- Novo Nordisk
- GlaxoSmithKline PLC
- Sanofi S.A. and Takeda Pharmaceuticals and others.
Request for Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/1593
Grab Holding Inc. Merged with SPAC, Valued at $40 Billion
On May 24th, 2021; Xeris Pharmaceuticals, Inc., a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable drug formulations, and Strongbridge Biopharma plc, a global commercial-stage biopharmaceutical company focused on the development and commercialization of medicines for rare diseases have entered into a definitive agreement under which Xeris will acquire Strongbridge for stock and contingent value rights.
Based on the closing price of Xeris common stock of $3.47 on May 21st, 2021, and Strongbridge’s fully diluted share capital, the agreement values Strongbridge at approximately $267 million, including the maximum aggregate amount payable under the CVRs. This is an extremely compelling transaction that will result in the formation of a scalable and diversified biopharmaceutical firm that will be more focused on specialty and rare disease therapies, preparing them for long-term product development and commercial success.
Increasing Prevalence of Chronic Diseases, Growing Number of FDA Approvals and Increasing Number of Product Launches are the Key Factors Driving the Market Growth
The market is largely driven by the increasing number of chronic diseases, and increasing innovation and new product launches in this market. According to the WHO, Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020 and diabetes was the direct cause of 1.5 million deaths in 2020. In addition, increasing FDA approvals for biopharmaceutical drugs is also one of the major factors fostering the growth of the bio-pharma market. For instance; in April 2021, U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death, and heart failure in adults with chronic kidney disease. In May 2021, FDA approved J & J drug-Rybrevant, which is the first for lung cancer with a particular genetic mutation. Due to these driving factors, the Bio-Pharma market is currently growing tremendously.
However, the development of biopharmaceutical drugs requires high investment which may hamper the market growth. In spite of that, demand for biopharmaceuticals is rising owing to their potential to cure diseases rather than merely treat symptoms. This can offer more opportunities for the further growth of the global bio-pharma market.
Key Benefits of Global Bio-Pharma Market Report–
- Global Bio-Pharma market report covers in depth historical and forecast analysis.
- Global Bio-Pharma market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global Bio-Pharma market report helps to identify opportunities in market place.
- Global Bio-Pharma market report covers extensive analysis of emerging trends and competitive landscape.
Complete Report Details @ https://brandessenceresearch.com/pharmaceutical/bio-pharma-market
Global Bio-Pharma Market is segmented into product, application and regional & country analysis. On the basis of product, the market is segmented into insulin, interferon, monoclonal antibody, growth and coagulation factor, vaccine, hormone, Erythropoietin and others. On the basis of application, the market is segmented into infectious disease, blood disorder, metabolic disease, cardiovascular disease, oncology, neurological disease, immunology and others.
Global Bio-Pharma Market Segmentation
- Monoclonal antibody
- Growth and coagulation factor
- Infectious disease
- Blood disorder
- Metabolic Disease
- Cardiovascular disease
- Neurological disease
- Immunology and
By Regional & Country Analysis: (North America, U.S., Canada, Europe, U.K., France, Germany, Italy,Asia Pacific, China, Japan, India, Southeast Asia, Latin America, Brazil, Mexico, Middle East and Africa, GCC, Africa, Rest of Middle East and Africa)
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global Bio-Pharma Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Bio-Pharma Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Bio-Pharma Market: Trends
2.8. Porter’s Five Forces Analysis
2.9. Market Attractiveness Analysis
3. Chapter – Global Bio-Pharma Market Overview: Quantitative Analysis
4. Chapter – Global Bio-Pharma Market Analysis: Segmentation By Type
5. Chapter – Global Bio-Pharma Market Analysis: Segmentation By Application
About Us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org
Formaldehyde Market Size: Global Formaldehyde Market is valued at USD 20.79 Billion in 2020 and expected to reach USD 28.58 Billion by 2027 with the CAGR of 4.65% over the forecast period.
Fuel Dispenser Market Size: The global demand for Fuel Dispenser market in terms of revenue was estimated to be USD 2.14 Billion in and is expected to reach USD 3.66 Billion by 2027, growing at a CAGR of 5.5% from 2021 to 2027.